SHJBF (Shanghai Junshi Biosciences Co) DeferredTaxAndRevenue: $0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHJBF Shanghai Junshi Biosciences Co Ltd SHJBF
74 GF Score
Price $3.35
GF Value $5.89
! 5 Warning Signs
View Full Analysis

What is Shanghai Junshi Biosciences Co DeferredTaxAndRevenue?

Shanghai Junshi Biosciences Co SHJBF +11.67% 74 DeferredTaxAndRevenue is $0.0 Mil as of Dec. 2025. GuruFocus rates SHJBF with a GF Score™ of 74/100 and a GF Value™ of $5.89. The stock has 5 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Shanghai Junshi Biosciences Co's current deferred tax and revenue for the quarter that ended in Dec. 2025 was $0.0 Mil.

Shanghai Junshi Biosciences Co DeferredTaxAndRevenue Related Terms

Shanghai Junshi Biosciences Co DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Shanghai Junshi Biosciences Co's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Junshi Biosciences Co DeferredTaxAndRevenue Chart

Shanghai Junshi Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Shanghai Junshi Biosciences Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHJBF
74GF Score
Shanghai Junshi Biosciences Co Ltd SHJBF
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.0 Mil mean?
Shanghai Junshi Biosciences Co (SHJBF) has a DeferredTaxAndRevenue of $0.0 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Shanghai Junshi Biosciences Co.
Is Shanghai Junshi Biosciences Co's DeferredTaxAndRevenue too high?
Shanghai Junshi Biosciences Co's current DeferredTaxAndRevenue is $0.0 Mil. Overall, Shanghai Junshi Biosciences Co has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Junshi Biosciences Co's DeferredTaxAndRevenue compare to VRTX and REGN?
Shanghai Junshi Biosciences Co's DeferredTaxAndRevenue of $0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Shanghai Junshi Biosciences Co. Shanghai Junshi Biosciences Co's current DeferredTaxAndRevenue is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Junshi Biosciences Co stock overvalued right now?
Shanghai Junshi Biosciences Co (SHJBF) has a current DeferredTaxAndRevenue of $0.0 Mil. The stock's GF Value™ is $5.89, compared to a current price of $3.35 — trading 43.1% below its estimated fair value. The current DeferredTaxAndRevenue is $0.0 Mil. Shanghai Junshi Biosciences Co's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Shanghai Junshi Biosciences Co (SHJBF), the current DeferredTaxAndRevenue is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Junshi Biosciences Co (SHJBF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co stock appears to be undervalued. The current stock price of $3.35 is trading 43.1% below its estimated GF Value™ of $5.89.

Key valuation signals for SHJBF:

  • DeferredTaxAndRevenue: $0.0 Mil
  • GF Value™: $5.89 vs. price of $3.35 (43.1% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the SHJBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Junshi Biosciences Co Business Description

Other Exchanges 01877:Hong Kong688180:China
Address No. 987 Cai Lun Road, Level 4, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is mainly involved in the discovery, development, and commercialisation of therapeutic drugs. It focuses on the development and commercialization of several kinds of drugs, ranging from monoclonal antibodies to various drug modalities, including small molecules, ADCs, bi-specific or multi-specific antibodies, fusion proteins, nucleic acid drugs, and vaccines, as well as the exploration of next-generation therapies, including those for cancer and autoimmune diseases. The Group's portfolio includes commercialized drugs such as Tuoyi, Junmaikang, Mindewei, and Junshida, as well as products in clinical studies or in the marketing application stage. Geographically, it derives maximum revenue from Mainland China, and the rest from USA, India, and other markets.
74GF Score

Get the complete analysis for SHJBF

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.35
Price
$5.89
GF Value